View Everolimus Patient Reviews | What is Your Opinion about Everolimus?
|
-
I am a Brazilian woman, 57…
I am a Brazilian woman, 57 years old submitted to heart transpl using everolimus as immunossupressant. I am experiencing several skin problems: acne, harshes and a severe occasional abdominal pain. but I still happy since I feeling all of these because my transplant was successful.
-
I am a Brazilian woman, 57…
I am a Brazilian woman, 57 years old submitted to heart transpl using everolimus as immunossupressant. I am experiencing several skin problems: acne, harshes and a severe occasional abdominal pain. but I still happy since I feeling all of these because my transplant was successful.
Everolimus
Everolimus for Tumors Associated with Carcinoid Syndrome - The ASCO Post:
Stents Farmacológicos com Everolimus no Tratamento de Lesões Coronárias Complexas na Prática Diária
Everolimus for Tumors Associated with Carcinoid Syndrome - The ASCO Post
Everolimus Shrinks Angiomyolipomas from Tuberous Sclerosis Complex
Everolimus Shrinks Angiomyolipomas from Tuberous Sclerosis Complex
Everolimus Shrinks Angiomyolipomas from Tuberous Sclerosis Complex
RAD001 – Everolimus by another name:
The mTOR pathway
In clinical terms the mTOR protein was one of the most si...
当院は無縁ですが、外注でも測れるような環境整うのでしょうか?大学とかは院内薬剤部でHPLC? @kadsho MMFとEverolimus
RT @mwang179: New Clinical Result: Phase III study shows Everolimus offers a better survival in patients with advanced breast cancer.
Resultater fra en RADIANT-2 studie presentert i The ASCO (American Society of Clinical Oncology). "Effekten av...
Résultats : « L'efficacité de l'everolimus plus octréotide LAR dans les tumeurs neuroendocriniennes avancées sont...
RT @NETCancerDay: Results from a RADIANT-2 study in The ASCO post. "The efficacy of everolimus plus octreotide LAR in advanced...
Everolimus as Primary Immunosuppression in Kidney Transplantation: Experience in Conversion From Calcineurin Inhibit...
Results from a RADIANT-2 study in The ASCO post. "The efficacy of everolimus plus octreotide LAR in advanced...